Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × olaparib × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 32 Breast Neoplasms 23 Triple Negative Breast Neoplasms 16 Prostatic Neoplasms 15 Fallopian Tube Neoplasms 11 Neoplasms 8 Pancreatic Neoplasms 6 Glioma 6 Endometrial Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Stomach Neoplasms 5 Small Cell Lung Carcinoma 5 Sarcoma 5 Fanconi Anemia, Complementation Group D1 5 Cholangiocarcinoma 5 Urinary Bladder Neoplasms 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Breast Cancer 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Osteosarcoma 3 Neoplasm Metastasis 3 Medulloblastoma 3 Lung Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Wilms Tumor 2 Uveal Melanoma 2

Interventions

Cisplatin 80 Fluorouracil 66 Paclitaxel 62 Radiotherapy 56 Oxaliplatin 51 Irinotecan 35 Docetaxel 34 Leucovorin 32 Carboplatin 30 Capecitabine 26 Radiation 25 Surgical Procedures, Operative 20 pembrolizumab 17 Drug Therapy 15 Bevacizumab 15 Cetuximab 14 Nivolumab 12 tislelizumab 11 Chemoradiotherapy 11 Albumin-Bound Paclitaxel 10 camrelizumab 9 S 1 (combination) 9 Neoadjuvant Therapy 9 Esophagectomy 9 nimotuzumab 8 durvalumab 8 Trastuzumab 8 Radiotherapy, Intensity-Modulated 7 Gefitinib 7 nedaplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03829345 2019-07-08

SOLAR

Royal Marsden NHS Foundation Trust

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡